Literature DB >> 7860133

67-kDa laminin-receptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancer.

G Gasparini1, M Barbareschi, P Boracchi, P Bevilacqua, P Verderio, P Dalla Palma, S Ménard.   

Abstract

Experimental studies have shown that the 67-kDa laminin receptor (LRec) is an important molecule for the interaction of tumour cells with the extracellular matrix, and that it plays a role in the early steps of angiogenesis and in tumour invasion and metastasis. We performed a multi-parametric study in 171 node-negative breast cancers, followed for a median time of 6 years, to verify whether determination of the LRec provides prognostic information in addition to intra-tumoral microvessel density (IMD), a measure of tumour angiogenesis, and to other biological and conventional indicators. A positive association between LRec expression and high neovascularization was found, although it did not reach significance. LRec was not associated either with other biological markers (oestrogen receptor, progesterone receptor and p53 expression) or to the conventional prognostic features [menopausal status, tumour size, histological types, grading and peri-tumoral lymphatic vessel invasion (PLVI)]. In univariate analysis, IMD, p53, PgR, PLVI, grading and tumour size were significant prognostic indicators of relapse-free survival (RFS). LRec expression approached significance when considered as a dichotomous variable, after having selected the optimum cutoff of 10% to distinguish high-risk from low-risk patients. For overall survival (OS), tumour size and IMD (continuous variable) were significant prognostic factors, and p53 approached significance. In multivariate analysis for RFS, the joint variable LRec and vascularization was the strongest independent prognostic factor, followed by PgR, PLVI and p53. For OS, tumour size was the only independent prognostic indicator in this series.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7860133     DOI: 10.1002/ijc.2910600506

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  High endothelial cell proliferation index and high microvessel density in vascular hotspots suggest an active angiogenic process in human colorectal adenocarcinomas. Angiogenesis Group.

Authors:  P B Vermeulen; L Y Dirix; E Van Marck; A T Van Oosterom
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

2.  Comprehensive proteomic analysis of nonintegrin laminin receptor interacting proteins.

Authors:  Lisa Venticinque; Daniel Meruelo
Journal:  J Proteome Res       Date:  2012-08-29       Impact factor: 4.466

3.  Prognostic value of intratumoral microvessel density, a measure of tumor angiogenesis, in node-negative breast carcinoma--results of a multiparametric study.

Authors:  P Bevilacqua; M Barbareschi; P Verderio; P Boracchi; O Caffo; P Dalla Palma; S Meli; N Weidner; G Gasparini
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

4.  Diminution of 37-kDa laminin binding protein expression reduces tumour formation of murine lung cancer cells.

Authors:  K Satoh; K Narumi; T Abe; T Sakai; T Kikuchi; M Tanaka; T Shimo-Oka; M Uchida; F Tezuka; M Isemura; T Nukiwa
Journal:  Br J Cancer       Date:  1999-06       Impact factor: 7.640

5.  Vascular grading of angiogenesis: prognostic significance in breast cancer.

Authors:  S Hansen; D A Grabau; F B Sørensen; M Bak; W Vach; C Rose
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

6.  Cellular and Molecular Changes in MNU-Induced Breast Tumours Injected with PF4 or bFGF

Authors:  Siti Norasikin Mohd Nafi; Fauziah Idris; Hasnan Jaafar
Journal:  Asian Pac J Cancer Prev       Date:  2017-12-28

7.  In vitro inhibition of angiogenesis by antibodies directed against the 37kDa/67kDa laminin receptor.

Authors:  Raksha Khusal; Bianca Da Costa Dias; Kiashanee Moodley; Clement Penny; Uwe Reusch; Stefan Knackmuss; Melvyn Little; Stefan F T Weiss
Journal:  PLoS One       Date:  2013-03-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.